TRDA Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Entrada Therapeutics Inc

Watchlist Manager

Watchlist

Price: 7.17 USD -1.78% Market Closed

Market Cap: $278.3m

	Entrada Therapeutics Inc NASDAQ:TRDA	US
C	China Merchants Bank Co Ltd F:M4B	CN
	Ava Risk Group Ltd ASX:AVA	AU
	InterContinental Hotels Group PLC F:IC1B	UK

Profitability Summary

Entrada Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-3 767%

Negative 3Y Average Operating Margin

-646%

Declining Operating Margin

-169% > -3 767%

Negative Net Margin

-3 538%

Negative 3Y Average Net Margin

-597%

Declining Net Margin

-190% > -3 538%

Negative Free Cash Flow Margin

-2 867%

Negative 3Y Average Free Cash Flow Margin

-495%

Declining Free Cash Flow Margin

251% > -2 867%

Negative ROE

-54%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-56%

Declining ROIC

-115% > -215%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.